ClinicalTrials.Veeva

Menu

Improving Treatment and Recovery Services for Individuals With Opioid Problems

Howard University logo

Howard University

Status

Unknown

Conditions

Counseling

Treatments

Behavioral: Recovery Guide Counseling

Study type

Observational

Funder types

Other
Industry
NIH

Identifiers

NCT05129813
IRB-18-MED-38
3UG1DA013034-20 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Participants include persons receiving buprenorphine treatment and Recovery Guide counseling in a Federally Qualified Health Center or buprenorphine treatment by telemedicine and Recovery Guide counseling in a church or faith-based community organization. Participants are interviewed at the outset of treatment, after 4 to 6 weeks, and then at 10 to 12 weeks of treatment. The study is an observational study aimed at evaluating the experiences and response to treatment of participants.

Full description

Participants include persons receiving buprenorphine treatment and Recovery Guide counseling in a Federally Qualified Health Center or buprenorphine treatment by telemedicine and Recovery Guide counseling in a church or faith-based community organization. Participants are interviewed at the outset of treatment, after 4 to 6 weeks, and then at 10 to 12 weeks of treatment. The study is an observational study aimed at evaluating the experiences and response to treatment of participants. Interviews use a semi-structured format assessing current and past opioid and other substance use, adherence to buprenorphine, and experiences with the counseling and other services provided.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Opioid use disorder
  • Initiating buprenorphine treatment

Exclusion criteria

  • Inability to understand the study protocol or assessment questions
  • Severe medical or psychiatric co-morbidity, including active psychosis, high risk for suicide, or medical contraindications to buprenorphine (e.g., allergy or sensitivity to buprenorphine),
  • Currently (or in the past 30 days) receiving MAT for OUD.

Trial design

20 participants in 2 patient groups

Buprenorphine MOUD in FQHC
Description:
Participants receiving buprenorphine treatment and Recovery Guide counseling in a Federally Qualified Health Center. Recovery Guide counseling is provided weekly.
Treatment:
Behavioral: Recovery Guide Counseling
Telemedicine Provision of Buprenorphine MOUD in a community site
Description:
Participants receiving buprenorphine treatment provided by telemedicine from a hub clinic and Recovery Guide counseling in a church or faith-based community organization. Recovery Guide counseling is provided weekly.
Treatment:
Behavioral: Recovery Guide Counseling

Trial contacts and locations

1

Loading...

Central trial contact

Denise Scott, Ph.D.; Richard Schottenfeld, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems